focus -WSS

focus

author：knowledge 2025-10-01 17:21:06 - browse：8

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT's guide to the next generation of CAR

Wikipedia

WSS

In areas with more Black doctors, Black people live longer

Do masks work? RCTs can't tell us

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

UnitedHealth, Optum discontinue NaviHealth name

The battle over the Brookhaven Landfill on Long Island

Weight bias in eating disorder treatment complicated by new weight loss drugs

entertainment

focus

focus

Hepatitis C has a cure — but many Americans still lack access to it

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

ChatGPT in medicine: STAT answers readers' burning questions

Colonoscopy at 40? Study finds a possible benefit

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: Live from the 2023 STAT Summit

Bright Health sells Medicare Advantage business to Molina

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Summit: Meghan O’Rourke on making chronic illness visible

hotspot

Why drug prescriptions should include diagnoses

Results on Novartis prostate cancer therapy could expand its use

The battle over the Brookhaven Landfill on Long Island

Study on Amgen’s bispecific immunotherapy produces positive data

Smaller biotechs seek to piggyback on weight loss drug boom

The problems with dementia villages

entertainment

focus

Wikipedia

entertainment